tradmap

AIDX 20/20 Biolabs, Inc.

$0.23 +7.65%

Data as of close

Industrials · Services-Testing Laboratories

20/20 Biolabs, Inc. (AIDX) is an industrial company in the Services-Testing Laboratories industry, with a market capitalization of $3 million. Shares last traded at $0.23. Net profit margin is -182.8%, below the peer median of 3.5%. Revenue grew 16.7% year over year.

Market Cap
$3M
Shares Out
12.8M
EPS (TTM)
-$0.76
P/E (TTM)*
—
P/S Ratio
1.42
P/B Ratio
1.80
Dividend / Share
—
Dividend Yield
—
52-Week High
—
52-Week Low
—
Volume (venue)
1,369
Avg Vol (3m, venue)
2,254.825

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-3.35%
1M
-41.48%
3M
-49.52%
6M
-86.09%
YTD
-99.04%
1Y
—

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
31.42
SMA (50)
$0.42
SMA (200)
—
Price vs SMA50
-45.59%
Price vs SMA200
—
ATR (14)
$0.02

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2M
Net Income
-$4M
Gross Margin
29.6%
Operating Margin
-162.9%
Net Margin
-182.8%
Return on Equity
-230.7%
Return on Assets
-61.1%
Current Ratio
1.99
Debt / Equity
1.83
Revenue Growth (YoY)
+16.7%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.26 2026-08-14
Q1 2026 -$0.28 2026-05-20
FY 2025 -$0.76 2026-03-31
Q2 2025 -$0.17 —
Q1 2025 -$0.16 —
FY 2024 -$1.16 —

Full earnings history →

Industrials peers

AIDX vs 14 sector peers (Industrials), by market cap. Data as of close

P/S vs peers
1.42 / 1.25 med
+14% premium
Net margin vs peers
-182.8% / 3.5% med
below median
1–14 of 14
VVisa$794.4B35.7318.4651.7%+2.84%
ASMLASML Holding$590.6B55.0516.1929.4%-2.34%
MAMastercard$573.6B33.8215.8146.7%+3.20%
LRCXLam Research$285.6B33.8010.9332.3%-4.40%
CATCaterpillar$282.1B26.023.7714.5%-1.58%
RTXRTX$273.6B32.562.858.8%+1.46%
APHAmphenol$197.1B33.235.9618.0%+0.67%
UNPUnion Pacific Corporation$182.4B23.956.9228.9%+1.01%
DEDeere & Company$180.0B36.943.7510.2%-1.14%
ACNAccenture$162.2B19.392.1911.3%+1.93%
LMTLockheed Martin$148.6B22.811.888.2%+0.95%
ETNEaton$143.0B37.354.7612.8%-0.67%
BABoeing$139.0B18.161.468.1%+2.31%
SPGIS&P Global$137.7B27.628.6631.3%+1.85%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.